B·R·A·H·M·S™ AFP KRYPTOR™

B·R·A·H·M·S provides a complete portfolio of biomarkers for the screening of fetal defects in first and second trimester of pregnancy and biomarkers for diagnosis and monitoring of cancer. B·R·A·H·M·S AFP KRYPTOR is indicated as an aid to be used in conjunction with clinical evaluation to help identify pregnancies at risk of trisomy 21 in first trimester, of trisomy 21 and 18 and neural tube defects in second trimester, and as an aid for the diagnosis and monitoring of patients with hepatocellular carcinomas or non-seminomatous germ cell tumors.

US Only: Product is not 510k cleared in US.

Get confidence in your results with the high precision of B·R·A·H·M·S AFP KRYPTOR and its short incubation time.

• Save cost and time with a multiparametric control containing 3 parameters: PAPP-A, Free βhCG and AFP
• Incubation time of only 9 minutes for a short turnaround time
• Allows measurement in serum, plasma (heparin) and amniotic fluid
• Large capacity with 75 tests
• Kit stable up to 15 days after opening onboard the instrument
• Easy workflow with only 1 calibrator and one calibration every 2 weeks
• Fits your throughput need with B·R·A·H·M·S KRYPTOR compact PLUS or B·R·A·H·M·S KRYPTOR GOLD
• Allows risk calculation in first and second trimester with B·R·A·H·M·S Fast screen pre I plus